| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 257.97B | 238.31B | 222.25B | 217.71B | 192.64B |
| Gross Profit | 89.09B | 86.05B | 80.41B | 76.82B | 69.86B |
| EBITDA | 79.59B | 58.88B | 55.54B | 54.48B | 43.95B |
| Net Income | 40.55B | 36.50B | 33.99B | 33.97B | 26.69B |
Balance Sheet | |||||
| Total Assets | 399.17B | 357.20B | 341.45B | 309.44B | 289.63B |
| Cash, Cash Equivalents and Short-Term Investments | 88.36B | 87.06B | 91.74B | 92.52B | 85.43B |
| Total Debt | 5.14B | 5.04B | 5.17B | 4.84B | 5.63B |
| Total Liabilities | 102.70B | 77.64B | 75.54B | 69.43B | 67.92B |
| Stockholders Equity | 295.35B | 278.53B | 265.00B | 239.18B | 220.93B |
Cash Flow | |||||
| Free Cash Flow | 21.47B | 12.64B | 12.22B | 17.11B | 19.98B |
| Operating Cash Flow | 35.87B | 28.98B | 29.97B | 23.33B | 27.39B |
| Investing Cash Flow | -4.43B | -13.75B | -14.96B | -709.00M | -8.76B |
| Financing Cash Flow | -31.41B | -22.02B | -17.10B | -16.17B | -15.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥532.18B | 21.74 | 6.52% | 1.82% | 4.95% | 52.94% | |
73 Outperform | ¥335.41B | 11.35 | 5.47% | 3.41% | 0.55% | 25.37% | |
71 Outperform | ¥633.80B | 15.48 | 12.15% | 1.58% | 8.25% | 14.61% | |
64 Neutral | ¥456.05B | 10.42 | 8.14% | 2.61% | -0.45% | 50.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥805.42B | 23.39 | 2.01% | 3.82% | -7.76% | 7.92% | |
58 Neutral | ¥951.15B | -24.55 | -2.50% | 3.49% | -4.57% | -190.44% |